Skip Navigation



Rheumatology Advance Access published online on September 12, 2007

Rheumatology, doi:10.1093/rheumatology/kem220
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/11/1652    most recent
kem220v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wakitani, S.
Right arrow Articles by Miyazaki, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wakitani, S.
Right arrow Articles by Miyazaki, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Serum keratan sulfate is a promising marker of early articular cartilage breakdown

S. Wakitani1, M. Nawata2, A. Kawaguchi1, T. Okabe3, K. Takaoka1, T. Tsuchiya4, R. Nakaoka4, H. Masuda5 and K. Miyazaki5

1Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, 2Department of Orthopaedic Surgery, Marunouchi Hospital, 3Department of Orthopaedic Surgery, Shinshu University School of Medicine, 4Division of Medical Devices, National Institute of Health Sciences, 5Department of Pharmaceuticals information, Seikagaku Corporation.

Correspondence to: Shigeyuki Wakitani, MD, Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi, Abeno-ku, Osaka 545-8585, Japan. E-mail: wakitani{at}med.osaka-cu.ac.jp


   Abstract

Objectives. To find serum markers that may serve as indices for an early diagnosis of degeneration or damage of the articular cartilage.

Methods. Twenty-four healthy volunteers, 19 individuals with knee trauma (KT) and 31 with knee osteoarthritis (OA) were evaluated. KT patients were divided into a group (n = 5) with an injury <2 months old (recent KT) and a group (n = 14) with that >2 months old (old KT). Articular cartilage damage was assessed using either arthroscopy or direct observation. Serum concentrations of hyaluronic acid (HA), cartilage proteoglycan aggrecan turnover epitope (CS846) and cartilage oligomeric protein (COMP) were measured using enzyme-linked immunosorbent assay kits and those of keratan sulfate (KS) and chondroitin-6-sulfate (C6S) using high-performance liquid chromatography.

Results. Serum KS in the recent KT group (2095 ± 594 ng/ml) was significantly higher than that in the old KT group (1373 ± 418 ng/ml; P = 0.021), and serum COMP in the recent KT group (1572 ± 182 ng/ml) showed a tendency that was higher than that in the old KT group (1350 ± 250 ng/ml; P = 0.079).

Serum KS in OA patients with Kellgren and Lawrence (KL) grades 0 and I (1456 ± 334 ng/ml) showed a tendency that was higher than that in OA patients with KL grades II, III and IV (1248 ± 220 ng/ml; P = 0.084).

Conclusions. The serum concentration of KS correlated with the damage of the articular cartilage and it was significantly increased even at an early stage after the injury.

KEY WORDS: Keratan sulfate, Glycosaminoglycan, Cartilage oligomeric protein, Cartilage injury, Osteoarthritis, Serum marker

Submitted 11 April 2007; revised version accepted 19 July 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.